Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue
| Authors | |
|---|---|
| Year of publication | 2025 |
| Type | Article in Periodical |
| Magazine / Source | EXPERIMENTAL AND MOLECULAR MEDICINE |
| MU Faculty or unit | |
| Citation | |
| web | https://www.nature.com/articles/s12276-025-01397-1 |
| Doi | http://dx.doi.org/10.1038/s12276-025-01397-1 |
| Keywords | tumor necrosis; human mucosal tissue; intestinal inflammation |
| Attached files | |
| Description | The intestine hosts the largest immune system and peripheral nervous system in the human body. The gut-brain axis orchestrates communication between the central and enteric nervous systems, playing a pivotal role in regulating overall body function and intestinal homeostasis. Here, using a human three-dimensional in vitro culture model, we investigated the effects of serotonin, a neuromodulator produced in the gut, on immune cell and intestinal tissue interactions. Serotonin attenuated the tumor necrosis factor-induced proinflammatory response, mostly by affecting the expression of chemokines. Serotonin affected the phenotype and distribution of tissue-migrating monocytes, without direct contact with the cells, by remodeling the intestinal tissue. Collectively, our results show that serotonin plays a crucial role in communication among gut-brain axis components and regulates monocyte migration and plasticity, thereby contributing to gut homeostasis and the progression of inflammation. In vivo studies focused on the role of neuromodulators in gut inflammation have shown controversial results, highlighting the importance of human experimental models. Moreover, our results emphasize the importance of human health research in human cell-based models and suggest that the serotonin signaling pathway is a new therapeutic target for inflammatory bowel disease. |
| Related projects: |